that Nck is likely to be an important signaling molecule.
elucidated the mechanism whereby SH2 domain-containing proteins without catalytic activity, such as Grb2- 3 Corresponding author and p85-associated PI3 kinase, regulate signal transduction pathways. SH2 domain-containing proteins in this group Nck, an adaptor protein composed of one SH2 and are tightly associated with catalytic molecules, and functhree SH3 domains, is a common target for a variety tion as adaptors linking these molecules to phosphotyroof cell surface receptors. We have identified a novel sine-containing proteins. Grb2 provides one of the best mammalian serine/threonine kinase that interacts with examples of how molecules in this group function to the SH3 domains of Nck, termed Nck Interacting regulate signal transduction pathways (Schlessinger, 1994 ; Kinase (NIK). This kinase is most homologous to the Pawson, 1995) . Grb2 is tightly associated via its SH3 Sterile 20 (Ste20) family of protein kinases. Of the domains to the Ras guanine nucleotide exchange factor, members of this family, GCK and MSST1 are most Son of sevenless (Sos). Following growth factor stimulasimilar to NIK in that they bind neither Cdc42 nor tion, binding of SH2 domains of Grb2 to the autophosRac and contain an N-terminal kinase domain with phorylated receptor localizes Sos adjacent to Ras in the a putative C-terminal regulatory domain. Transient plasma membrane, thereby enabling Sos to activate Ras. overexpression of NIK specifically activates the stressNck is a ubiquitously expressed protein which is comactivated protein kinase (SAPK) pathway. Both the kinase domain and C-terminal regulatory region of posed of one SH2 and three SH3 domains and, like Grb2, NIK are required for full activation of SAPK. NIK does not contain homology to any known catalytic domains likely functions upstream of MEKK1 to activate and thus fits into the adaptor class of signaling molecules this pathway; a dominant-negative MEK kinase 1 (Lehman et al., 1990) . Several findings have indicated (MEKK1) blocks activation of SAPK by NIK. MEKK1 that Nck is likely to be an important signaling molecule.
and NIK also associate in cells and this interaction is
First, Nck is an oncoprotein; cellular overexpression of mediated by regulatory domains on both proteins. Two Nck results in transformation of NIH 3T3 cells and 3Y1 other members of this kinase family, GCK and HPK1, rat fibroblasts (Chou et al., 1992; Li et al., 1992) . Secondly, contain C-terminal regulatory domains with homology Nck is a common target for a variety of growth factor to that of NIK. These findings indicate that the receptors and becomes phosphorylated on serine, threonine C-terminal domain of these proteins encodes a new and tyrosine residues after growth factor stimulation (Chou protein domain family and suggests that this domain et al., 1992; Li et al., 1992; Park and Goo Rhee, 1992) . couples these kinases to the SAPK pathway, possibly
More recently, genetic screens in Drosophila have indiby interacting with MEKK1 or related kinases.
Introduction
Over the past couple of years, several effector molecules that interact with the SH3 domains of Nck have been Over the past several years it has become apparent that identified. These domains have been shown to bind Sos, while different signaling molecules may contain distinct Cbl, the Wiskott-Aldrich syndrome protein (WASP) and catalytic activities, most share several conserved protein a 65 kDa serine/threonine kinase which is likely to be a domains (Schlessinger, 1994; Cohen et al., 1995; Pawson, member of the PAK 65 family (Rivero-Lezcano et al., 1995) . These domains are critical for regulating signal 1994 , 1995 Bagrodia et al., 1995; Chou and Hanafusa, transduction pathways, and function by mediating protein-1995; Hu et al., 1995; Galisteo et al., 1996) . However, protein or protein-lipid interactions. For example, two for the most part, the biological significance of these domains frequently found on signaling molecules are SH2 interactions is still not known. For example, while overand SH3 domains (Schlessinger, 1994; Cohen et al., 1995;  expression of Nck under some circumstances leads to Ras Pawson, 1995). SH2 domains bind to a phosphotyrosine moiety in the context of short amino acid sequences activation and thus may be accounted for by the interaction of Nck with Sos, dominant inhibitory Nck molecules do 1A) (Hanks and Hunter, 1995) . The middle portion of NIK contains two proline-rich sequences that match consensus not block activation of Ras by Abl or the epidermal growth factor receptor (EGFR) (Tanaka et al., 1995) . In sequences important in mediating SH3-domain binding to protein targets and are responsible for the interaction of addition, the biological significance of Nck binding Cbl or WASP is still not known.
NIK with Nck in the yeast two-hybrid system (see Figure  4B ) (Yu et al., 1994) . The C-terminal portion of NIK In the hope of further elucidating the role of Nck in growth factor signaling, we undertook studies to identify lacks any obvious sequence motifs. However, data presented below strongly suggest that this regions plays an proteins that bind the SH3 domains on Nck. Here, we report the identification of a novel serine/threonine kinase, important regulatory role in NIK function. The NIK kinase domain is most similar to the p21 NIK (Nck Interacting Kinase), which binds the SH3 domains of Nck in vitro and in vivo. Transient overexpresactivated kinase (PAK) Ste20 family of protein kinases ( Figure 1B ) (Ramer and Davis, 1993; Katz et al., 1994 ; sion of NIK activates the MEKK1/MKK4/SAPK pathway, and full activation of this pathway requires both a func- Manser et al., 1994; Creasy and Chernoff, 1995; Martin et al., 1995) . Of the members in this group identified thus tional kinase and a conserved C-terminal regulatory domain. Interestingly, we found that the C-terminal regufar, NIK is structurally most similar to human GCK and MST1 and yeast Sps1 in that NIK does not bind the GTPlatory domain of NIK interacts with MEKK1. In addition, this domain is conserved in two other members of this bound form of either Cdc42Hs or Rac1 (data not shown) and contains an N-terminal kinase domain with a putative kinase family, thereby identifying a previously undescribed binding domain. Upstream regulators of MEKK1 are still C-terminal regulatory domain (Friesen et al., 1994; Creasy and Chernoff, 1995; Pombo et al., 1995) . largely unknown. These findings suggest that NIK directly modulates MEKK1 activity in vivo. NIK and related Interestingly, NIK is most homologous to a gene identified in the Caenorhabditis elegans genome sequencing kinases may provide a link by which adaptor proteins such as Nck couple receptors to the JNK/SAPK pathway.
project and is likely the mammalian homologue of this gene ( Figure 1C ). No function has yet been described to the C.elegans gene, nor has it been characterized at the
Results
mRNA or protein level. NIK is 52% identical and 68% similar overall to the C.elegans gene (data not shown). Identification of NIK using the yeast two-hybrid system and subsequent cDNA cloning Moreover, the kinase and C-terminal domains of the two proteins are even more conserved; NIK and the C.elegans We screened for proteins that interact with the SH3 domains of Nck using the yeast two-hybrid system. We gene are 86% similar and 72% identical between these two domains ( Figure 1C and data not shown). The identified several partial cDNA clones that interacted specifically with Nck. The proteins encoded by the clones C-terminal domain of NIK is also similar to the regulatory domains of two other kinases in this group, GCK and interacted with the Nck-LexA fusion, but not with LexA coupled to a variety of other cDNAs (data not shown).
HPK1 ( Figure 1C ) (Katz et al., 1994; Pombo et al., 1995; Hu et al., 1996) . The strong conservation of the NIK All clones contained at least one proline motif that matched consensus motifs previously shown to be critical for C-terminus with the C.elegans gene and with GCK and HPK1 suggested to us that this domain plays an important interaction of SH3 domains with target proteins (Yu et al., 1994) . One clone was found to encode a partial sequence regulatory role in NIK function. Northern hybridization analysis was performed on of a serine/threonine protein kinase, termed NIK, which is the focus of this report.
various human tissues using cl 16 as a probe ( Figure 2A ). This analysis demonstrated the presence of two major The clone identified in the yeast two-hybrid system contained 528 nucleotides (corresponding to amino acids bands of 4.5 and 6.5 kb in most tissues, with highest 443-619 of full-length NIK). To identify the full-length NIK cDNA, an adult mouse brain cDNA library (Stratagene) was screened using the DNA isolated from the two-hybrid screen. Several overlapping clones were identified, the largest of which (cl 16) was~3 kb. Cl 16 contained a single large open reading frame followed by a polyadenylation signal and a long 3Ј untranslated region of~1000 nucleotides. Since the insert from cl 16 did not contain the 5Ј end of the gene, an embryonic mouse brain cDNA library (Stratagene) was screened using the 5Ј 250 nucleotides of cl 16 as a probe. This approach enabled us to identify three additional overlapping clones that extended 5Ј from cl 16. One of these clones, cl 11, contained the 5Ј end of the gene; this clone contained an AUG codon that met Kozak translation initiation criteria as well as a stop codon that was 5Ј and in-frame to this predicted translation start site (Kozak, 1989) .
Analysis of the full-length gene demonstrated three regions of homology to other genes in the database. The N-terminus of NIK contains 11 subdomains that are characteristic of serine/threonine protein kinases ( Figure Fig only the kinase domain also had full kinase activity ( Figure  3C ). These findings confirm that NIK is a protein kinase.
NIK binds Nck in cells and interacts specifically with the SH3 domains of Nck via two proline-rich motifs
To confirm that NIK interacts with the SH3 domains of Nck, as well as to assess whether NIK binds SH3 domains present in other proteins, we determined whether NIK bound GST fusions containing the SH3 domains of a variety of proteins. Myc-epitope-tagged NIK was transfected into 293 cells and binding of NIK in the transfected cell lysates to several GST fusions was assessed. NIK bound a GST fusion protein containing either full-length or the three SH3 domains of Nck ( Figure 4A ). In contrast to the association of NIK with Nck, NIK interacted only weakly with GRB2 and we were unable to detect association of NIK with SH3 domains from a variety of other proteins ( Figure 4A ). While several of these SH3-domain fusion proteins did not bind NIK, they were able to bind proline motifs present in a related kinase, human PAK1 (data not shown), indicating that these fusion proteins were functional. We also identified the proline motifs that mediated the labeled clone identified in the yeast two-hybrid system. association of NIK with the SH3 domains of Nck. NIK contains two proline motifs that match consensus SH3 binding sites ( Figure 1A , shown in bold) (Yu et al., 1994;  expression in the brain and heart. The 4.5 kb message corresponds to the expected size which codes for the clone Mayer and Eck, 1995) . Both of these motifs were also contained in the partial cDNA isolated using the yeast that we isolated.
two-hybrid screen. To determine which of these prolinerich sequences mediates the association of NIK with Nck, NIK encodes a protein kinase of 140 kDa The predicted molecular mass of full-length NIK was the two proline residues in each motif were mutated to alanine and binding to Nck was determined. Mutations iñ140 kDa. To confirm that the NIK cDNA encoded a protein of this molecular mass, the full-length NIK cDNA either proline motif markedly decreased binding of NIK to an Nck-GST fusion protein in vitro ( Figure 4B ), was transfected into 293 cells and transfected cell lysates were immunoblotted with antibodies to NIK. Antibodies although the second motif was more critical for binding Nck. These findings are consistent with the idea that highto NIK specifically recognized a protein of 140 kDa in cells transfected with NIK, but not in cells transfected affinity binding of Nck to NIK requires the simultaneous engagement of two of Nck's SH3 domains with the two with a vector control ( Figure 3A ), thereby confirming that the NIK cDNA encodes a protein of the predicted proline-rich sequences in NIK. In addition to binding Nck in vitro, NIK also bound molecular mass.
To determine whether NIK has kinase activity, 293 cells Nck in cells. 293 cells were transiently transfected with Myc-epitope-tagged NIK and the ability of NIK to associwere transfected with NIK and an immune complex kinase assay was performed on NIK immunoprecipitates using ate with endogenous Nck in cells was assessed by determining whether the two proteins co-immunoprecipitate. myelin basic protein (MBP) as a substrate. While kinase activity was detected in NIK immunoprecipitates from Transfection of 293 cells with NIK led to the association of the two proteins as demonstrated by the co-immunopre-293 cells transfected with vector alone, kinase activity was markedly increased in cells transfected with NIK cipitation of Nck with NIK using either anti-Myc or antiNck antibodies ( Figure 4C ). In summary, these findings ( Figure 3B ). The kinase activity immunoprecipitated by the anti-NIK antibody was specific; preimmune serum did indicate that NIK and Nck interact in cells and that the interaction is mediated via the SH3 domains of Nck. The not immunoprecipitate kinase activity ( Figure 3B ). In addition to MBP, two other proteins of 140 and 35 kDa inability of a variety of other SH3 domains to bind NIK suggests that NIK may be a specific downstream target were also phosphorylated in the immune complex kinase assay. The band at 140 kDa is autophosphorylated NIK, for Nck. while the band at 35 kDa has not been identified. To rule out the possibility that a kinase co-precipitating with NIK NIK activates the MKK4-JNK/SAPK MAP kinase pathway accounted for the kinase activity, a Myc epitope-tagged kinase-defective NIK mutant in which the conserved Several distinct MAP kinase modules have been identified in yeast and mammalian cells (Minden et al., 1994 ; aspartic acid at position 152 was mutated to asparagine [NIK(D152N)] was also transiently expressed in 293 Sanchez et al., 1994; Yan et al., 1994; Herskowitz, 1995 Figure 3C ). A truncated NIK protein containing 1995; Pombo et al., 1995) . To determine whether NIK with an epitope-tagged SAPK or MKK4, and kinase activity was performed on SAPK and MKK4 precipitates. activates this pathway, we assessed whether overexpression of NIK activates MKK4 and JNK. MKK4 is one of Overexpression of NIK led to a 3-to 4-fold activation of both MKK4 and SAPK compared with cells transfected the kinases responsible for directly phosphorylating and activating JNK/SAPK (Sanchez et al., 1994 ; Derijard with vector control (Figure 5A and B). This magnitude of SAPK activation by NIK was similar to the activation et al., 1995) . 293 cells were transfected with NIK, together To assess activation, the various kinase were precipitated from 500 μg of cell lysates and subjected to an in vitro kinase reaction using GST-Jun (A), GST-p38 (B) or MBP (C) as substrates (upper panel). Reaction products were separated by SDS-PAGE and visualized by autoradiography. To ensure that equal amounts of kinases were immunoprecipitated between samples, one-half of the immunoprecipitate was immunoblotted with αGST (A and B) or αMyc (C) antibodies (lower panel). of this pathway by two known activators of JNK, MEKK1 and UV light ( Figure 5A ). Although NIK activates MKK4 and SAPK, it does not activate the Ras-p42 MAP kinase pathway; while overexpression of an activated Ras led to a marked increase in p42 MAP kinase activation, overexpression of NIK did not ( Figure 5C ). We did not detect activation of either p38, MKK3 or MKK6 by NIK overexpression as assessed by co-transfection of epitopetagged versions of these proteins with NIK (Han et al., 1996;  data not shown).
NIK activation of JNK requires the activation of MEKK1 and MKK4
To confirm that NIK signals through MKK4 to activate Figure 5A , with the exception that either kinase dead MKK4(K→R) or defective MKK4(K129R) blocks NIK activation of JNK ΔMEKK1(K→R) were included in the transfections as indicated. (Sanchez et al., 1994; Han et al., 1996) . MKK4(K129R) Activation of GST-tagged JNK/SAPK and immunoblotting were has previously been shown to function as a dominantassessed as described in Figure 5 . negative molecule to inhibit JNK activation (Sanchez et al., 1994) . In support of the idea that NIK signals through MKK4 to activate JNK, co-expression of MKK4 (K129R) with HA-tagged full-length MEKK1 (Xu et al., 1996) together with Myc-epitope-tagged NIK and the ability of together with NIK and epitope-tagged JNK inhibited JNK activation by NIK ( Figure 6A ).
NIK and MEKK1 to associate was determined by assessing whether the two proteins co-immunoprecipitate. We found MEKK1 is a MAP kinase kinase kinase that has been shown to activate MKK4. ΔMEKK1 containing an arginine that MEKK1 co-immunoprecipitated with NIK as demonstrated by the co-immunoprecipitation of HA-epitopefor lysine substitution in the ATP binding domain [ΔMEKK1(K-R)] is kinase-defective and functions as a tagged MEKK1 with anti-myc antibodies ( Figure 7A) . Moreover, the association of MEKK1 with NIK was dominant-negative molecule to inhibit endogenous MEKK1 (Yan et al., 1994) . Co-expression of a mediated through the interaction of the N-terminus of MEKK1 with the C-terminus of NIK. The N-terminal 719 ΔMEKK1(K-R) together with NIK inhibited the activation of JNK by NIK ( Figure 6B ). ΔMEKK1(K-R) also inhibited amino acids of MEKK1 and the C-terminal regulatory domain ( Figure 1C ) of NIK were sufficient to mediate the activation of JNK by UV light (data not shown). These findings raise the possibility that NIK functions upstream the association of the two proteins ( Figure 7A ). These interactions were specific; we did not detect association of MEKK1 to activate JNK. However, we cannot rule out the possibility that ΔMEKK1(K-R) is functioning as a of NIK with the C-terminal 320 amino acids of MEKK1 (ΔMEKK1) ( Figure 7B ; Yan et al., 1994) . dominant-negative by binding and inactivating MKK4; under this scenario, inhibition by ΔMEKK1(K-R) would only confirm that NIK signals through MKK4 to activBoth NIK's kinase activity and C-terminus are required for full activation of the JNK/SAPK ate JNK. pathway As discussed above, we found that the C-terminal domain MEKK1 and NIK associate in vivo To begin to address whether NIK may directly regulate of NIK and GCK are 22% identical over 330. Expression of the regulatory region of GCK without the kinase domain MEKK1 we determined whether MEKK1 and NIK coimmunoprecipitate. 293 cells were transiently transfected activates SAPK (Pombo et al., 1995) . Therefore, we were To assess whether MEKK1 and NIK associate in cells, NIK was immunoprecipitated from transfected cell lysates using the anti-myc antibody 9E10. The washed immunoprecipitates were separated by SDS-PAGE and associated MEKK1 was assessed by immunoblotting with antibodies to HA. (B) As a control, an EE-tagged MEKK1 containing only the C-terminal domain of MEKK1 (ΔMEKK1) was co-transfected with NIK. The ability of NIK and EE-tagged ΔMEKK1 to co-immunoprecipitate was assessed as described in (A), with the exception that ΔMEKK1 was detected using a monoclonal antibody to the EE epitope tag (Babco).
interested in determining whether the C-terminus of NIK indicate that both NIK's kinase activity and C-terminal domain are required for NIK to fully activate the SAPK and GCK function similarly to activate the SAPK pathway. In addition, we wanted to determine whether NIK required pathway in cells. The finding that the C-terminal domain of NIK by itself is capable of activating SAPK and ATF2 a functional kinase and C-terminus to activate this pathway. To address this, several truncated NIK proteins as well as reporter activity, together with the finding that a truncated NIK protein lacking the C-terminus fails to fully activate a kinase-defective NIK [NIK(D152N)] were expressed in 293 cells and JNK activation was determined. In agreement this pathway, suggests that the C-terminal domain of NIK plays an important regulatory role, possibly via its with the results obtained with GCK, expression of the C-terminal domain of NIK alone stimulated a small interaction with MEKK1 or related molecules. increase in SAPK activity when compared with full-length NIK ( Figure 8A ). However, full activation of SAPK by Discussion NIK required both NIK's kinase activity and C-terminus; while overexpression of NIK resulted in a~5-fold increase
We have identified a novel serine/threonine kinase, NIK, that interacts with the SH3 domains of Nck. Overexpresin SAPK activity, expression of the kinase domain alone (data not shown) or NIK(D152N) consistently resulted in sion of NIK constitutively activated the JNK/SAPK pathway. NIK interacts with MEKK1 in cells and likely signals only a 2-to 2.5-fold increase in SAPK activity.
We were able to confirm these results by examining through MEKK1 to activate JNK, suggesting that NIK directly regulates MEKK1 activity. We found that NIK whether these same NIK constructs activate an ATF2-stimulated luciferase reporter gene ( Figure 8C ); SAPK contains a regulatory domain in its C-terminus that is conserved in two other members of this kinase family. has been shown to phosphorylate and activate several transcription factors including ATF2 .
This domain mediates the association of NIK with MEKK1 and is critical for NIK activation of the SAPK pathway, NIK or the various NIK constructs described above were co-transfected into 293 cells together with a plasmid suggesting that the C-terminal domain of these proteins encodes a new protein domain family that couples these expressing a fusion protein consisting of the activation domain of ATF2 and the DNA binding domain of GAL4 kinases to the SAPK pathway, possibly by interacting with MEKK1. Our finding that NIK also interacts with Nck and a plasmid expressing a GAL4 luciferase reporter . Overexpression of NIK led to a~20-suggests that SH2/SH3 adaptor proteins couple NIK and related kinases to activation of the SAPK/JNK pathway fold increase in the transcriptional activity of ATF2 ( Figure  8B ). In agreement with the results presented above, by different receptors. Studies in Saccharomyces cerevisiae have shown that overexpression of the NIK C-terminus, the kinase domain or NIK(D152N) also consistently stimulated ATF2 trana serine/threonine kinase, Ste20, acts upstream of the S.cerevisiae MEKK Ste11 and downstream of the pheroscriptional activity, although the increase in luciferase activity was 5-to 10-fold less than that obtained with mone hormone receptor (Herskowitz, 1995) . Two families of protein kinases that are closely related to Ste20 in the wild-type NIK. The increase in ATF2 transcriptional activity was dependent upon phosphorylation of ATF2; kinase domain have been identified in mammalian cells. The first family of mammalian Ste20-related kinases are increased ATF2 transcriptional activity by NIK was markedly decreased when threonine at position 71 was activated by binding GTP-bound Cdc42 and Rac and, based on this characteristic, have been termed PAKs for mutated to alanine . These findings cascades are diverse, each module is activated by sequential phosphorylation of highly conserved components (Davis, 1994; Cobb and Goldsmith, 1995; Herskowitz, 1995) . The MAP kinase modules are composed of three protein kinases that act sequentially to stimulate a kinase cascade and are composed of a MAP kinase, an enzyme that activates MAP kinase (known as a MAP kinase kinase or MEK) and a kinase that activates MEK (known as MAP kinase kinase kinase or MEKK). At least six distinct MAP kinase modules have been identified in yeast and three distinct MAP kinase modules have been found in mammalian cells (Herskowitz, 1995) . While this system allows for crosstalk between the different pathways, for the most part these pathways function independently of one another in both yeast and mammals. The finding that NIK activates the JNK/SAPK MAP kinase pathway, but fails to activate the ERK MAP kinase cascade, indicates that NIK also maintains specificity by activating only one of the several MAP kinase cascades.
The mechanism whereby specificity is imparted to different MAP kinase pathways is not known. It has been proposed that scaffolding proteins impart specificity and regulate the activation of only a single MAP kinase cascade by binding and therefore juxtaposing all members of a particular cascade. For example, the yeast protein STE5 functions as a scaffolding protein in S.cerevisiae and binds STE20, STE11 and STE7 via non-overlapping regions (Choi et al., 1994; Marcus et al., 1994) . NIK may Yan et al., 1994) , regulatory elements upstream activity is expressed in arbitrary units after being standardized to of MEKK1 have been poorly characterized. In some β-galactosidase activity.
instances, Ras has been shown to function upstream of MEKK1 in mammalian cells . However, it is clear that MEKK1 is also regulated p21 Activated Kinases (Manser et al., 1994; Bagrodia et al., 1995; Martin et al., 1995) . The second family of by pathways that do not involve Ras. Based upon studies in yeast, it has been proposed that a mammalian homologue Ste20 homologues, which includes GCK and MST1, lack Cdc42 and Rac binding domains (Katz et al., 1994;  Creasy of Ste20/PAK regulates MEKK1 in mammalian cells (Herskowitz, 1995) . However, direct evidence for a PAK and Chernoff, 1995; Pombo et al., 1995) . In addition, in contrast to PAKs which contain an N-terminal regulatory family member activating an MEKK in mammalian cells
has not yet been published. While we have been unable and a C-terminal kinase domain, members of this second family contain an N-terminal kinase domain and to prove definitively that NIK directly regulates MEKK1, our finding that NIK and MEKK1 co-immunoprecipitate, C-terminal regulatory region. NIK fits into this second family of Ste20 homologues. Within this family, NIK is coupled with the finding that dominant-negative MEKK1 blocks JNK/SAPK activation by NIK, suggests that NIK most similar functionally and structurally to GCK and HPK1 (Pombo et al., 1995) . First, these kinases are directly regulates MEKK1 activity in vivo. Therefore, NIK is a good candidate for upstream regulation of MEKK1 constitutively active when transiently overexpressed in cells, and overexpression of all three kinases results in by a PAK/Ste20 family member.
Since the kinase domain of MEKK1 is constitutively activation of the MKK4-SAPK MAP kinase pathway. Second, these kinases share a conserved C-terminal reguactive when isolated from cells transiently transfected with the full-length MEKK1 cDNA, we have been unable latory domain ( Figure 1C ).
While the upstream signals that regulate MAP kinase to assess whether NIK activates MEKK1Јs kinase activity.
In contrast to previous studies that overexpressed truncated regulate specific MEKKs, and that this regulation is mediated by direct protein-protein interaction. versions of MEKK1, we have overexpressed the fullThe role of NIK binding to Nck in NIK regulation length MEKK1 clone (Minden et al., 1994; Yan et al., and NIK activation of the JNK/SAPK pathway is most 1994; Xu et al., 1996) . Thus, it is unlikely that the MEKK1 intriguing. One possibility is that subcellular targeting of clone we used is constitutively active based upon the lack NIK by Nck in growth factor-stimulated cells localizes of a critical negative regulatory domain. A previous report NIK adjacent to MEKK1, thereby enabling the two prohas suggested that the endogenous MEKK1 is inactive teins to interact. The finding that MEKK1 is found . It is possible that under predominantly in the particulate fraction (Xu et al., 1996) physiological levels of expression, MEKK1 is kept inactive suggests that binding of the SH2 domains of Nck to by interacting with a negative regulator. Overexpression autophosphorylated receptors, or to other tyrosine-phosof MEKK1 may titrate out a negative regulator and allow phorylated proteins in growth factor-stimulated cells, local-MEKK1 activation. The finding that NIK binds MEKK1 izes NIK to a similar subcellular compartment as MEKK1. raises the possibility that overexpression of NIK activates
In support of this idea, NIK is recruited to the platelet-MEKK1 by displacing this putative negative regulator derived growth factor receptor (PDGFR) in cells transifrom MEKK1. Alternatively, although not mutually ently transfected with epitope-tagged NIK (data not exclusive, phosphorylation of MEKK1 by NIK, possibly shown). Thus far, we have been unable to assess subcellular facilitated by the interaction of the C-terminus of NIK localization of endogenous NIK or whether external factors with MEKK1, may induce a conformational change that regulate NIK's kinase activity due to the fact that endocontributes to MEKK1 activation; this would account for genous NIK protein is present in low abundance. our finding that NIK's kinase activity is required for full Several lines of evidence now place Nck as an important activation of the SAPK pathway.
adaptor molecule coupling receptors to reorganization of The C-terminus of NIK is highly conserved between the cytoskeleton. The finding that Nck binds WASP, a mouse NIK, its C.elegans homologue (contained in cosmid protein responsible for mediating the effect of CDC42Hs Zc504) and two related kinases, GCK and HPK1 (Pombo on reorganization of the actin cytoskeleton, together Hu et al., 1996) . These findings, coupled the finding that a Drosophila protein related to Nck, with the demonstration that this domain mediates the DOCK, also couples receptors to cytoskeletal changes, association of NIK with MEKK1, suggest that the raises the possibility that NIK participates in regulating C-terminal regions in these proteins may encode a new this pathway (Rivero-Lezcano et al., 1995 ; Aspenstrom protein domain family that mediates protein-protein interet al., 1996; Garrity et al., 1996; Symons et al., 1996) . action. Moreover, the finding that overexpression of the The potential ability of Nck's three SH3 domains simul-C-terminus of NIK by itself activates the SAPK pathway, taneously to bind several different effector molecules together with the finding that a truncated NIK lacking its raises the possibility that crosstalk among the different C-terminus fails to fully activate this pathway, is consistent molecules bound to Nck's SH3 domains determines biowith the idea that this domain couples NIK to the SAPK logical response. Future studies will focus on the upstream pathway in vivo, possibly via the interaction with MEKK1.
signals that regulate NIK, how NIK regulates the JNK/ NIK's kinase activity, however, is required for maximal SAPK pathway, and on determining whether NIK is stimulation; activation of JNK/SAPK signaling by overinvolved in mediating cytoskeletal changes by Nck. expressing the C-terminal domain or a kinase-defective NIK was less than that observed for the wild-type NIK.
Only one previous study has demonstrated interaction of 
Materials and methods

Constructs, epitope tagging, mutagenesis and transient cell
After 48 h, cells were lysed and NIK was immunoprecipitated using expression either the anti-myc antibody 9E10 or the anti-NIK antibody described All NIK constructs were expressed in the cytomegalovirus-based expresabove. The immune complex was then washed three times with lysis sion vector pRK5 (Li et al., 1992) . The NIK kinase domain (amino buffer and twice with kinase buffer (20 mM HEPES, pH 7.4, 10 mM acids 1-310) and C-terminus (amino acids 908-1233) of NIK were MgCl 2 , 20 mM β-glycerophosphate, 10 mM NaF, 0.2 mM orthovanadate obtained by PCR using full-length NIK as a template. Both constructs and 1 mM dithiothreitol). After a 30 min incubation at 30°C in kinase were Myc-epitope-tagged at their C-terminus as described below and a buffer containing 10 μCi [γ-32 P]ATP and 5 μg MBP, the kinase reaction Kozak sequence was incorporated into the 5Ј oligonucleotide of the was terminated by adding an equal volume of 2ϫ sample buffer and the C-terminal construct to enable expression in mammalian cells (Kozak reaction products were separated by SDS-PAGE (12.5%). et al., 1989) . GST-tagged JNK/SAPK and ΔMKK4(K-R) were expressed Immune complex kinase reactions using JNK/SAPK or MKK4 were using the vector pEBG (Sanchez et al., 1994; Yan et al., 1994) .
performed as described previously (Han et al., 1996) . Briefly, epitopeHemagglutinin (HA)-tagged MKK4 was expressed using the vector tagged JNK/SAPK or MKK4 were co-transfected into 293 cells with pCDNA3 (Han et al., 1996) . The C-terminal 320 amino acids of EE-NIK or with vector control. At 24 h after transfection, cells were serumepitope-tagged ΔMEKK1 and ΔMEKK1(K-R) were expressed in the starved overnight in DMEM containing 0.2% FBS, lysed and precipitated vector pRK5 (Yan et al., 1994) . Dominant-negative MKK4 and dominantusing glutathione-agarose. An in vitro kinase assay was then performed negative ΔMEKK1 contained a K→R mutation in the ATP binding site on the precipitates as described above. GST-c-jun (containing amino of the kinase domain (Yan et al., 1994; Han et al., 1996) . Full-length acids 1-223) coupled to glutathione-agarose was used as a substrate for HA-tagged MEKK1 and MEKK1(1-719) have been described previously JNK/SAPK and GST-p38 coupled to glutathione-agarose was used as a (Xu et al., 1996) . The GAL4-ATF2 and GAL4-ATF2(T71A) are in the substrate for MKK4 (Kallunki et al., 1994; Minden et al., 1994 ; Han vector pSG424 as described previously (Sadowski and Ptashne, 1989) et al., 1996) . NIK was Myc-epitope-tagged (DQKLISEEDL) at the C-terminus SAPK kinase activity using GST-c-Jun (containing amino acids 1-using PCR and cloned into pRK5. Briefly, an oligonucleotide was 223 of c-Jun) coupled to glutathione-agarose beads was determined by synthesized containing the 3Ј end of NIK followed by the Myc epitope incubating 500 μg of lysates from 293 cells transfected with the various sequence, a stop codon and a convenient restriction site. This 3Ј cDNAs with 10 μg of GST-c-Jun for 2 h at 4°C. After washing the oligonucleotide was used in a PCR reaction to generate a C-terminal beads three times with lysis buffer and twice with kinase buffer, the fragment of NIK which was then used to replace an XbaI-HindIII kinase reaction was started by incubating beads in 25 μl kinase buffer fragment in the 3Ј end of full-length NIK.
containing 20 μM non-radiolabelled ATP and [γ-32 P]ATP (15 μCi per For site-directed mutagenesis, NIK was subcloned into the vector sample). After incubation at 30°C for 20 min, the reaction was terminated pALTER (Promega), and mutagenesis was performed according to the by boiling the mixtures in sample buffer for 5 min and the reaction manufacturer's specification. To facilitate screening of mutants, novel products were separated by SDS-PAGE (12%). restriction sites were incorporated into the oligonucleotides used for mutagenesis, and mutant NIK constructs were identified by restriction Reporter assays digest. The NIK mutants were subcloned back into pRK5 for expression A fusion protein consisting of ATF2 (amino acids 1-505) and the GAL4 in 293 cells. The following oligonucleotides were used:
DNA binding domain was expressed in 293 cells either alone or together NIK(D152N) 5Ј-CGTTATTCACCGAAATATTAAGGGCCAwith NIK . Transcriptional activation of ATF2 was AAAT measured by co-transfecting a luciferase reporter plasmid containing 5ϫ NIK(P574A,P577A) 5Ј-CCGCTCTCAGGATGCATGTCCAGCTTC-GAL4 DNA binding domains. All transfections were standardized CCGCAGT by co-transfecting a control plasmid expressing β-galactosidase NIK(P611A,P614A) 5Ј-GACGAGGTGCCTGCAAGGGTTGCCGT-(Promega). GAGAACGA 293 cells were transfected with Ca 2 (PO 4 ) 3 as previously described
Accession number
The NIK sequence has been submitted to the DDBJ/EMBL/GenBank; (Chen and Okiyama, 1987) . accession number U88984.
GST fusions and in vitro binding studies
Oligonucleotides flanking the regions of interest and containing appropriate restriction sites were synthesized and PCR was used to amplify
